TychoBio IVS: Financial statements 2020
CVR: 37211265
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TychoBio IVS (CVR 37211265) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -2,388. Equity in the 2020 report amounted to DKK 1,395. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -2,388
- Equity
- DKK 1,395
- Total Assets
- DKK 1,395
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | -2 t. | 1 t. | - |
| 2018 | 0 | -65 t. | 19 t. | 16 t. | - |
| 2017 | 0 | -40 t. | -30 t. | 6 t. | - |
| 2016 | - | 46 t. | 36 t. | 36 t. | - |
Official annual report
How creditworthy is TychoBio IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
TychoBio IVS has published its interim report for the period November 1, 2018 – December 31, 2019.
About TychoBio IVS
TychoBio IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2015. The company has been dissolved on 13 April 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -2,388. Equity in the 2020 report amounted to DKK 1,395.